Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Clinical trial NCT02104323 · COMPLETED
Trial details
- NCT number
- NCT02104323
- Sponsor
- Beijing Tiantan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.